Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
12-year community-based cohort study investigated whether 1-h glucose concentration could be better indicator of diagnosis.
Read More »Using The One-Hour Postload Glucose Can Predict Future Diabetes
FDA: Boxed Warning: Amputation Risk for Canagliflozin
Post-marketing trial data show doubled rates compared to placebo.
Read More »Breastfeeding Helps to Prevent Type 1 Diabetes
Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.
Read More »GLP-1 Receptor Agonist for Type 1’s
Besides lowering A1c, study finds success with using less insulin and weight reduction.
Read More »Effects of Adding Metformin to Insulin in Type 1 Children and Adolescents
A low-risk intervention with potentially high rewards.
Read More »Liraglutide Reduces Liver Fat Content in Patients With Poorly Controlled Type 2 Diabetes
A proposed benefit of GLP-1 agonists confirmed in a human study.
Read More »New AACE Lipid Guidelines Establish ‘Extreme’ CVD Risk Category
In a departure from recommendations by cardiology societies, two endocrine groups issue new lipid-management guidelines that bring back LDL-cholesterol targets.
Read More »The Future For Insulin Pumps
Guest writer David Kliff of Diabetic Investor explains why he doesn't expect any closed-loop systems to expand the overall insulin pump market by any significant amount.
Read More »AACE: Complete Reversal of Type 2 Diabetes With GLP-1 Agonist
Retrospective analysis presentation shows liraglutide (LIRA) improved glycemic parameters, reduced body weight, BMI, and waist circumference in new T2 patients.
Read More »Sulfonylureas No More!
Cheapest treatment associated with increased risks of cardiovascular events and death.
Read More »